FDA Guidance Reformats Annual Reports for PMA Products

After a device receives PMA approval, its manufacturer must file a report annually with FDA updating it on manufacturing, design, and labeling changes, among other things. For years, it appeared, very little was ever done with this information. But in this era of heightened postmarket surveillance, CDRH would like to see annual reports reformatted to better highlight potential safety issues. Today, it released a draft guidance outlining how it would like to see annual reports formatted. The public has 90 days to submit comments.

October 26, 2006

1 Min Read
FDA Guidance Reformats Annual Reports for PMA Products

"Annual reports that contain well developed and meaningful information will be an important tool for the agency and the industry to assure postmarket safety and protect the public," the agency states in the document. "When manufacturers prepare the type of analysis this guidance describes and provide this information to FDA in annual reports, industry and FDA will be better positioned to recognize and address possible safety signals." Let's hope so.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like